Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 8 | 2019 | 311 | 2.110 |
Why?
|
| Emergency Service, Hospital | 15 | 2018 | 467 | 1.610 |
Why?
|
| Acute Coronary Syndrome | 11 | 2017 | 194 | 1.310 |
Why?
|
| Professional Competence | 2 | 2020 | 19 | 1.120 |
Why?
|
| Myocardial Infarction | 9 | 2018 | 473 | 1.010 |
Why?
|
| Chest Pain | 9 | 2018 | 205 | 0.930 |
Why?
|
| Body Surface Potential Mapping | 4 | 2012 | 12 | 0.830 |
Why?
|
| Emergency Medicine | 4 | 2019 | 115 | 0.820 |
Why?
|
| Nursing Staff | 1 | 2020 | 8 | 0.700 |
Why?
|
| Social Perception | 1 | 2020 | 24 | 0.700 |
Why?
|
| Liability, Legal | 1 | 2018 | 24 | 0.610 |
Why?
|
| Schools, Medical | 1 | 2018 | 42 | 0.610 |
Why?
|
| Curriculum | 2 | 2018 | 213 | 0.580 |
Why?
|
| Career Choice | 1 | 2016 | 43 | 0.540 |
Why?
|
| Subcutaneous Emphysema | 1 | 2014 | 3 | 0.490 |
Why?
|
| Decision Support Techniques | 4 | 2017 | 128 | 0.490 |
Why?
|
| Telemedicine | 1 | 2016 | 102 | 0.480 |
Why?
|
| Lower Extremity | 1 | 2014 | 100 | 0.450 |
Why?
|
| Critical Pathways | 4 | 2018 | 49 | 0.440 |
Why?
|
| Laparoscopy | 1 | 2014 | 172 | 0.430 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 36 | 0.410 |
Why?
|
| Humans | 30 | 2020 | 32082 | 0.400 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 53 | 0.400 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 107 | 0.390 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2010 | 83 | 0.380 |
Why?
|
| Risk Assessment | 4 | 2016 | 1427 | 0.360 |
Why?
|
| Emergency Treatment | 1 | 2010 | 42 | 0.350 |
Why?
|
| Postoperative Complications | 1 | 2014 | 780 | 0.330 |
Why?
|
| Algorithms | 1 | 2012 | 496 | 0.330 |
Why?
|
| Electrocardiography | 8 | 2016 | 604 | 0.320 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2008 | 30 | 0.310 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 881 | 0.300 |
Why?
|
| Female | 19 | 2020 | 19999 | 0.260 |
Why?
|
| Clinical Competence | 2 | 2018 | 331 | 0.250 |
Why?
|
| Cardiology Service, Hospital | 2 | 2015 | 23 | 0.230 |
Why?
|
| Adult | 12 | 2020 | 9375 | 0.230 |
Why?
|
| Prospective Studies | 3 | 2020 | 2282 | 0.220 |
Why?
|
| Troponin | 6 | 2016 | 106 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2013 | 1325 | 0.210 |
Why?
|
| Aged | 12 | 2018 | 10308 | 0.200 |
Why?
|
| United States | 6 | 2020 | 3975 | 0.190 |
Why?
|
| Predictive Value of Tests | 6 | 2017 | 873 | 0.190 |
Why?
|
| Male | 18 | 2018 | 19202 | 0.190 |
Why?
|
| Search Engine | 1 | 2020 | 3 | 0.180 |
Why?
|
| Medical Staff, Hospital | 2 | 2011 | 20 | 0.180 |
Why?
|
| Middle Aged | 15 | 2018 | 11834 | 0.180 |
Why?
|
| Public Opinion | 1 | 2020 | 17 | 0.180 |
Why?
|
| Patient Admission | 2 | 2011 | 58 | 0.180 |
Why?
|
| Personnel Selection | 1 | 2019 | 13 | 0.170 |
Why?
|
| Documentation | 1 | 2019 | 46 | 0.170 |
Why?
|
| School Admission Criteria | 1 | 2019 | 11 | 0.170 |
Why?
|
| Sensitivity and Specificity | 4 | 2017 | 581 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 99 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 103 | 0.160 |
Why?
|
| Myocardial Revascularization | 2 | 2015 | 41 | 0.160 |
Why?
|
| Coronary Angiography | 3 | 2018 | 153 | 0.150 |
Why?
|
| Exercise Test | 3 | 2016 | 225 | 0.140 |
Why?
|
| Troponin C | 1 | 2017 | 9 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 765 | 0.140 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 516 | 0.140 |
Why?
|
| Patient Discharge | 2 | 2015 | 186 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 94 | 0.130 |
Why?
|
| Perception | 1 | 2016 | 101 | 0.130 |
Why?
|
| Death | 1 | 2015 | 49 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2016 | 118 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2017 | 1816 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2016 | 354 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2020 | 3505 | 0.120 |
Why?
|
| Decision Making | 1 | 2016 | 194 | 0.120 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.110 |
Why?
|
| Angina Pectoris | 1 | 2013 | 22 | 0.110 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.110 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 62 | 0.110 |
Why?
|
| North Carolina | 5 | 2016 | 1538 | 0.110 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.100 |
Why?
|
| Transients and Migrants | 1 | 2016 | 297 | 0.100 |
Why?
|
| Observer Variation | 1 | 2012 | 105 | 0.100 |
Why?
|
| Arteriovenous Malformations | 1 | 2012 | 8 | 0.100 |
Why?
|
| Neurofibromatosis 1 | 1 | 2012 | 9 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2012 | 203 | 0.100 |
Why?
|
| Cataract Extraction | 1 | 2012 | 11 | 0.100 |
Why?
|
| Carotid Artery, Common | 1 | 2012 | 39 | 0.100 |
Why?
|
| Hospital Costs | 1 | 2011 | 37 | 0.100 |
Why?
|
| Health Expenditures | 1 | 2011 | 65 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 510 | 0.090 |
Why?
|
| Inpatients | 1 | 2011 | 83 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2011 | 115 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 127 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2011 | 160 | 0.080 |
Why?
|
| Hispanic Americans | 1 | 2016 | 940 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 184 | 0.080 |
Why?
|
| Teaching | 1 | 2009 | 63 | 0.080 |
Why?
|
| Anticoagulants | 1 | 2010 | 122 | 0.080 |
Why?
|
| Physicians | 1 | 2011 | 159 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 3990 | 0.080 |
Why?
|
| Atherectomy | 1 | 2008 | 4 | 0.080 |
Why?
|
| Ticlopidine | 1 | 2008 | 17 | 0.080 |
Why?
|
| Length of Stay | 3 | 2015 | 312 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 62 | 0.070 |
Why?
|
| Risk Factors | 4 | 2017 | 3880 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2008 | 100 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2008 | 114 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 407 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 299 | 0.060 |
Why?
|
| Cost Savings | 2 | 2016 | 33 | 0.060 |
Why?
|
| Time Factors | 3 | 2015 | 2145 | 0.060 |
Why?
|
| Costs and Cost Analysis | 2 | 2016 | 99 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2020 | 26 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 24 | 0.040 |
Why?
|
| Linear Models | 2 | 2011 | 448 | 0.040 |
Why?
|
| Contracts | 1 | 2019 | 6 | 0.040 |
Why?
|
| Prognosis | 2 | 2015 | 1496 | 0.040 |
Why?
|
| Correspondence as Topic | 1 | 2019 | 3 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2263 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2019 | 122 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2012 | 917 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2016 | 37 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2016 | 97 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2016 | 142 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 99 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2015 | 27 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 876 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 895 | 0.030 |
Why?
|
| Observation | 1 | 2013 | 25 | 0.030 |
Why?
|
| Age Factors | 1 | 2016 | 1187 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1199 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2012 | 20 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 25 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2013 | 126 | 0.030 |
Why?
|
| Face | 1 | 2012 | 29 | 0.020 |
Why?
|
| Models, Economic | 1 | 2011 | 19 | 0.020 |
Why?
|
| Faculty | 1 | 2011 | 17 | 0.020 |
Why?
|
| Drug Costs | 1 | 2011 | 46 | 0.020 |
Why?
|
| Adenosine | 1 | 2011 | 58 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 753 | 0.020 |
Why?
|
| Dobutamine | 1 | 2011 | 68 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 125 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 158 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 185 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 252 | 0.020 |
Why?
|
| Heart | 1 | 2011 | 176 | 0.020 |
Why?
|
| Internet | 1 | 2011 | 197 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 43 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 483 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2009 | 525 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2010 | 177 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 468 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 1542 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2010 | 3304 | 0.010 |
Why?
|